Importantly, TIP30 levels in relation to its target eEF1A are markedly downregulated in failing and cardiomyopathic human hearts, which according to our findings leave eEF1A active and thereby promotes cardiac hypertrophy and failure. Here, EEF1A1 is linked to cardiac hypertrophy.